本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

奥洛兹美医疗

65.87
-1.8600-2.75%
盘后66.550.6800+1.03%18:29 EDT
成交量:250.17万
成交额:1.68亿
市值:81.17亿
市盈率:17.52
高:69.94
开:68.11
低:65.68
收:67.73
数据加载中...
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/26

重要事件披露

Form 8-K - Current report
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities